Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Traws Pharma, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 24 | 28 | +4 |
| Shares | 1.86M | 1.78M | −74.0K (−4.0%) |
| Value | $2.19M | $1.27M | −$919.4K (−42.0%) |
New holders (6)
Institutions that held Traws Pharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 30,713 | $22.2K | 0.00% |
| Two Sigma Securities, LLC | 10,929 | $7.78K | 0.00% |
| TD Waterhouse Canada Inc. | 120 | $87 | 0.00% |
| JPMorgan Chase & Co | 25 | $18 | 0.00% |
| Qube Research & Technologies Ltd | 3 | $2 | 0.00% |
| Simplex Trading, LLC | 107 | $0 | 0.00% |
Sold out (2)
Institutions that held Traws Pharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Signaturefd, LLC | 400 | $472 |
| FMR LLC | 3 | $4 |